Skip to main content
Clinical Trials/NCT05396651
NCT05396651CompletedNot Applicable

Effect of Low Fodmap Diet on Control of Pediatric Irritable Bowel Syndrome

Sarah Abdelrahman El Ezaby1 site in 1 country80 target enrollmentStarted: October 2, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
improvement of irritable bowel syndrome symproms

Study Overview

Brief Summary

To evaluate the impact of low FODMAP diet on Health related Quality of life in children with Irritable bowel syndrome according to ROME IV criteria in a group of patients in pediatric Hospital at Ain Shams University

Detailed Description

Single blinded randomized two-arm intervention study in which 42 patients with irritable bowel syndrome were enrolled to study the effect of LOW FODMAP diet ( intervention group) on their gastrointestinal symptoms and their quality of life another group of 42 patients of IBS were enrolled as a control group who were received general diet instructions and they followed the NICE guide lines for IBS management

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
5 Years to 15 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •children aged 5-15 years old fulfilling ROME IV criteria of IBS diagnosis

Exclusion Criteria

  • •Patients presenting with :
  • •Abdominal pain or diarrhea that wakes the child from sleep
  • •Delay in onset or progression of puberty.
  • •Faltering growth.
  • •Family history of inflammatory bowel disease, celiac disease.
  • •History of significant weight loss .
  • •Bleeding per rectum.
  • •Persistence of severe vomiting or diarrhea
  • •. Persistent joint pain.
  • •Recurrent unexplained fever.
  • •Unexplained pallor

Arms & Interventions

LOW FODMAP Diet group

Experimental

42 Children aged 5-15 years old fulfilling ROME IV criteria of IBS diagnosis, and didn't have any of the following :o Abdominal pain or diarrhea that wakes the child from sleep

  • Delay in onset or progression of puberty.
  • Faltering growth.
  • Family history of inflammatory bowel disease, celiac disease.
  • History of significant weight loss .
  • Bleeding per rectum.
  • Persistence of severe vomiting or diarrhea
  • . Persistent joint pain.
  • Recurrent unexplained fever.
  • Unexplained pallor they followed the low fodmapdiet for 6 weeks

Intervention: low fodmap diet (Other)

NICE guidelines group

Placebo Comparator

42 Children aged 5-15 years old fulfilling ROME IV criteria of IBS diagnosis and didn't have one of the following : o Abdominal pain or diarrhea that wakes the child from sleep

  • Delay in onset or progression of puberty.
  • Faltering growth.
  • Family history of inflammatory bowel disease, celiac disease.
  • History of significant weight loss .
  • Bleeding per rectum.
  • Persistence of severe vomiting or diarrhea
  • . Persistent joint pain.
  • Recurrent unexplained fever.
  • Unexplained pallor

they followed NICE guidelines for irritable bowel syndrome for 6 weeks

Intervention: NICE guidelines for IBS (Other)

Outcomes

Primary Outcomes

improvement of irritable bowel syndrome symproms

Time Frame: 6 weeks

Change in Pediactric Quality of life inventory (PedsQL) gastrointestinal symptoms module score

Secondary Outcomes

  • improve patients quality of life(6 weeks)

Investigators

Sponsor
Sarah Abdelrahman El Ezaby
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Sarah Abdelrahman El Ezaby

Family Medicine assistant lecturer at Faculty of Medicine

Ain Shams University

Study Sites (1)

Loading locations...

Similar Trials